Directorate Change | 17-Apr-2024 | 11:30 | RNS |
Appointment of Administrators | 20-Mar-2024 | 15:43 | RNS |
Intention to Appoint Administrators | 20-Mar-2024 | 12:30 | RNS |
Block Listing Review & Total Voting Rights | 01-Mar-2024 | 07:00 | RNS |
Suspension - ReNeuron Group plc | 05-Feb-2024 | 14:30 | RNS |
Corporate update and suspension of trading on AIM | 05-Feb-2024 | 14:30 | RNS |
Interim Results for the six months ended 30 Sept | 08-Nov-2023 | 07:01 | RNS |
ReNeuron presents in vivo data at Cell 2023 | 08-Nov-2023 | 07:00 | RNS |
R&D Update | 04-Sep-2023 | 07:00 | RNS |
Block Listing Review & Total Voting Rights | 01-Sep-2023 | 07:00 | RNS |
Director declaration | 29-Aug-2023 | 07:00 | RNS |
Result of AGM | 22-Aug-2023 | 10:34 | RNS |
Notice of AGM | 24-Jul-2023 | 17:20 | RNS |
Share Purchase by Chief Financial Officer | 12-Jul-2023 | 11:57 | RNS |
Share Purchase by Senior Independent NED | 16-Jun-2023 | 17:12 | RNS |
Currency | UK Pounds |
Share Price | 3.38p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 11.13 |
52 Week Low | 3.38 |
Volume | 0 |
Shares Issued | 57.17m |
Market Cap | £1.93m |
RiskGrade | 394 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
You are here: research